Measuring and diagnosis of high blood pressure (hypertension) should be done using systolic blood pressure only in patient’s grey over 50 years, degree than using both systolic and diastolic as is current business.

Even if high blood pressure does cause symptoms, the symptoms are usually mild and nonspecific .Thus, high blood pressure often is labeled “the silent killer.”People who have high blood pressure typically don’t know it until their blood pressure is measured.

The risk of cardiovascular disease rises continuously as SBP increases from 115 mm Hg. Most international and national guidelines advocate a target of below 140 mm Hg, but there is a lack of evidence from prospective randomized clinical trials to define the best target for SBP treatment. The authors say: “Such trials are much needed and perhaps our call for a renewed focus on SBP will provide a catalyst for them to be designed.”

The patient will improve awareness and understanding of treatment objectives, and will ultimately lead to more effective treatment of high blood pressure. Such an initiative would have major public-health implications for the prevention of blood-pressure related cardiovascular disease.

It is of utmost importance to realize that high blood pressure can be unrecognized for years, causing no symptoms but causing progressive damage to the heart, other organs, and blood vessels.